complete remission of nephrotic syndrome and acute kidney injury in crescentic iga nephropathy: role of mycophenolate sodium

Clicks: 229
ID: 167268
2016
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Optimal therapy and prognosis of crescentic-IgA nephropathy (C-IgAN) are not known. Reported treatment options for C-IgAN include combination of corticosteroids and cyclophosphamide for 6 months. The role of mycophenolate sodium in C-IgAN is unknown. We report a case of C-IgAN that was successfully treated with combination immunosuppressive therapy.
Reference Key
bhandari2016indiancomplete Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;D Bhandari;K D Jhaveri;H H Shah
Journal journal of the chemical society - perkin transactions 1
Year 2016
DOI
10.4103/0971-4065.175985
URL
http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2016;volume=26;issue=5;spage=370;epage=372;aulast=Bhandari
Keywords
acute kidney injury iga nephropathy urology glomerular diseases mycophenolate sodiumdiseases of the genitourinary system

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.